autologous stem cell transplant
A bone marrow transplant using stem cells taken from the patient’s own bone marrow. These stem cells are collected and stored at an early disease stage or after treatment that has not controlled the disease. The marrow may be manipulated in the laboratory to try to reduce the risk of contamination with malignant cells and to increase the stem cell numbers. There are no problems with tissue matching, so this type of procedure may be carried out on patients in their 60s.
Last updated on April 17th, 2023
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.